BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 16324159)

  • 1. Evolution of migraine after a 10-year follow-up.
    Nachit-Ouinekh F; Dartigues JF; Chrysostome V; Henry P; Sourgen C; El Hasnaoui A
    Headache; 2005; 45(10):1280-7. PubMed ID: 16324159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variability of reported headache symptoms and diagnosis of migraine at 12 months.
    Nachit-Ouinekh F; Chrysostome V; Henry P; Sourgen C; Dartigues JF; El Hasnaoui A
    Cephalalgia; 2005 Feb; 25(2):117-23. PubMed ID: 15658948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of menstrual headache and an open-label study among those with previously undiagnosed menstrually related migraine to evaluate the efficacy of sumatriptan 100 mg.
    Schreiber CP; Cady RK
    Clin Ther; 2007; 29 Suppl():2511-9. PubMed ID: 18164918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and diagnosis of migraine in patients consulting their physician with a complaint of headache: data from the Landmark Study.
    Tepper SJ; Dahlöf CG; Dowson A; Newman L; Mansbach H; Jones M; Pham B; Webster C; Salonen R
    Headache; 2004 Oct; 44(9):856-64. PubMed ID: 15447694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Headache and transient focal neurological symptoms during pregnancy, a prospective cohort.
    Ertresvåg JM; Zwart JA; Helde G; Johnsen HJ; Bovim G
    Acta Neurol Scand; 2005 Apr; 111(4):233-7. PubMed ID: 15740574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic burden of transformed migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study.
    Munakata J; Hazard E; Serrano D; Klingman D; Rupnow MF; Tierce J; Reed M; Lipton RB
    Headache; 2009 Apr; 49(4):498-508. PubMed ID: 19245386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pivotal moment in 50 years of headache history: the first American Migraine Study.
    Tepper SJ
    Headache; 2008 May; 48(5):730-1; discussion 732. PubMed ID: 18471125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of migraine in patients with a history of self-reported or physician-diagnosed "sinus" headache.
    Schreiber CP; Hutchinson S; Webster CJ; Ames M; Richardson MS; Powers C
    Arch Intern Med; 2004 Sep; 164(16):1769-72. PubMed ID: 15364670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Sinus, Allergy and Migraine Study (SAMS).
    Eross E; Dodick D; Eross M
    Headache; 2007 Feb; 47(2):213-24. PubMed ID: 17300361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis of migraine headaches in adolescents: a 10-year follow-up study.
    Monastero R; Camarda C; Pipia C; Camarda R
    Neurology; 2006 Oct; 67(8):1353-6. PubMed ID: 17060559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Women's issues of migraine in tertiary care.
    Kelman L
    Headache; 2004 Jan; 44(1):2-7. PubMed ID: 14979877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis of migraine and tension-type headache: a population-based follow-up study.
    Lyngberg AC; Rasmussen BK; Jørgensen T; Jensen R
    Neurology; 2005 Aug; 65(4):580-5. PubMed ID: 16116119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognosis of childhood headache: a 20-year follow-up.
    Brna P; Dooley J; Gordon K; Dewan T
    Arch Pediatr Adolesc Med; 2005 Dec; 159(12):1157-60. PubMed ID: 16330740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recognition and management of migraine in primary care: influence of functional impact measured by the headache impact test (HIT).
    De Diego EV; Lanteri-Minet M
    Cephalalgia; 2005 Mar; 25(3):184-90. PubMed ID: 15689193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Migraine changes with age: IMPACT on migraine classification.
    Kelman L
    Headache; 2006; 46(7):1161-71. PubMed ID: 16866720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognition and therapeutic management of migraine in 2004, in France: results of FRAMIG 3, a French nationwide population-based survey.
    Lucas C; Géraud G; Valade D; Chautard MH; Lantéri-Minet M
    Headache; 2006 May; 46(5):715-25. PubMed ID: 16643573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of migraine diagnoses in adolescents: a 3-year annual survey.
    Wang SJ; Fuh JL; Juang KD; Lu SR; Hsu LC; Chen WT; Pwu RF
    Cephalalgia; 2005 May; 25(5):333-8. PubMed ID: 15839847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Headache in Behçet's syndrome.
    Saip S; Siva A; Altintas A; Kiyat A; Seyahi E; Hamuryudan V; Yazici H
    Headache; 2005; 45(7):911-9. PubMed ID: 15985109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study.
    Tepper SJ; Cady R; Dodick D; Freitag FG; Hutchinson SL; Twomey C; Kuhn TA
    Headache; 2006 Jan; 46(1):115-24. PubMed ID: 16412159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.